Chemring is well placed as warfare evolves

in
Opinion

The recent announcement by UK Defence Secretary John Healey regarding the mothballing of five Royal Navy warships as part of a £500 million cost-cutting drive has raised concerns about the state of the country’s defence capabilities. However, a closer look reveals that the vessels in question have been inactive for an extended period and were not part of combat-ready forces.

One of the ships, HMS Bulwark, was undergoing a major refit and facing recruitment shortages, leading to its uncertain status. With budget constraints looming, the situation may not improve unless drastic measures are taken. The decision to retire outdated helicopters and a drone system is part of ongoing rationalization efforts, with further measures expected ahead of next year’s strategic defence review.

Investors eyeing the aerospace/defence sector should take note of the evolving landscape, particularly in light of the conflict in Ukraine. The use of unmanned aerial vehicles (UAVs) in the conflict has highlighted the need for effective countermeasures, creating opportunities for smaller defence contractors like Chemring. The company’s advancements in AI-powered technologies for detecting and neutralizing UAV threats have positioned it well in the market.

Recent contracts worth £278 million, including a framework agreement for military applications with Diehl Defence, have bolstered Chemring’s order book and drawn positive attention from analysts. The ongoing conflict in Ukraine is likely to shape future defence procurement decisions, with a focus on innovation and asymmetrical warfare strategies.

Reports from the House of Lords and the European Defence Agency emphasize the need for increased resources and coordination in response to the Ukraine conflict. This presents a promising outlook for smaller contractors like Chemring, which stands to benefit from the evolving defence landscape.

See also  Bearbull Income Portfolio: The case for Plus500

Despite recent successes, Chemring still has a 23% upside potential according to analysts, with a consensus recommendation of ‘buy’. The company’s focus on countermeasures and energetics division is expected to drive revenue and profit growth in the medium term, making it an attractive investment opportunity in the aerospace/defence sector.

Tags :

Chemring, evolves, warfare

Share This Post :